Raymond James Financial’s Disc Medicine IRON Stock Holding History

Raymond James Financial’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.7M	Buy	77,980 +33,280	+74%	+$2.29M	﹤0.01%	2627
2026 Q1	$2.73M	Sell	44,700 -35,574	-44%	-$2.47M	﹤0.01%	3098
2025 Q4	$6.18M	Sell	80,274 -61,205	-43%	-$5.17M	﹤0.01%	2340
2025 Q3	$9.35M	Buy	141,479 +54,992	+64%	+$3.27M	﹤0.01%	1973
2025 Q2	$4.58M	Buy	86,487 +3,211	+4%	+$151K	﹤0.01%	2437
2025 Q1	$4.13M	Sell	83,276 -4,726	-5%	-$263K	﹤0.01%	2460
2024 Q4	$5.58M	Buy	+88,002	New	+$5.09M	﹤0.01%	2258

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Raymond James Financial's IRON Position: Q2 2026 in Review

Raymond James Financial increased its Disc Medicine (IRON) stake by 74% in Q2 2026, buying an estimated $2.29M and bringing the position to 77,980 shares worth $5.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2627.

Raymond James Financial first reported a position in IRON in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.35M in Q3 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

Raymond James Financial held 77,980 shares of Disc Medicine worth $5.7M as of Q2 2026.
Raymond James Financial bought 33,280 Disc Medicine shares in Q2 2026, an estimated $2.29M.
Disc Medicine made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2627 holding.
Raymond James Financial first reported a position in Disc Medicine in Q4 2024 and has held it in 7 quarters since.
Raymond James Financial's Disc Medicine position peaked at $9.35M in Q3 2025.
216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.